Evidence map›Paper›PMID 32512835›Full record

ArticleBiomedicines2020

A Human DUB Protein Array for Clarification of Linkage Specificity of Polyubiquitin Chain and Application to Evaluation of Its Inhibitors.

Hirotaka Takahashi, Satoshi Yamanaka, Shohei Kuwada, Kana Higaki, Kohki Kido, Yusuke Sato, Shuya Fukai, Fuminori Tokunaga, Tatsuya Sawasaki

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Research progress of DUB enzyme in breast cancer.Clinical and experimental medicine · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Hirotaka TakahashiProteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.ORCID 0000-0002-1278-416X
Satoshi YamanakaProteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.
Shohei KuwadaProteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.
Kana HigakiProteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.
Kohki KidoProteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.
Yusuke SatoCenter for Research on Green Sustainable Chemistry, Tottori University, Tottori 680-8552, Japan.
Shuya FukaiDepartment of Chemistry, Graduate School of Science, Kyoto University, Kyoto 606-8502, Japan.
Fuminori TokunagaDepartment of Pathobiochemistry, Graduate School of Medicine, Osaka City University, Osaka 545-8585, Japan.ORCID 0000-0003-3626-9119
Tatsuya SawasakiProteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.
Ehime University · JPKyoto University · JPOsaka City University · JPTottori University · JP

Funding

Japan Agency for Medical Research and Development JP19am0101077Japan Society for the Promotion of Science JP15K18468; JP17K07261; JP19H05292; JP16H06579; JP19H03218; JP17J08477; JP16H06575; JP18H02619; JP19K22541; JP15H01175; JP18H05501
6 · The paper itself

Abstract

Protein ubiquitinations play pivotal roles in many cellular processes, including homeostasis, responses to various stimulations, and progression of diseases. Deubiquitinating enzymes (DUBs) remove ubiquitin molecules from ubiquitinated proteins and cleave the polyubiquitin chain, thus negatively regulating numerous ubiquitin-dependent processes. Dysfunctions of many DUBs reportedly cause various diseases; therefore, DUBs are considered as important drug targets, although the biochemical characteristics and cellular functions of many DUBs are still unclear. Here, we established a human DUB protein array to detect the activity and linkage specificity of almost all human DUBs. Using a wheat cell-free protein synthesis system, 88 full-length recombinant human DUB proteins were prepared and termed the DUB array. In vitro DUB assays were performed with all of these recombinant DUBs, using eight linkage types of diubiquitins as substrates. As a result, 80 DUBs in the array showed DUB activities, and their linkage specificities were determined. These 80 DUBs included many biochemically uncharacterized DUBs in the past. In addition, taking advantage of these active DUB proteins, we applied the DUB array to evaluate the selectivities of DUB inhibitors. We successfully developed a high-throughput and semi-quantitative DUB assay based on AlphaScreen technology, and a model study using two commercially available DUB inhibitors revealed individual selectivities to 29 DUBs, as previously reported. In conclusion, the DUB array established here is a powerful tool for biochemical analyses and drug discovery for human DUBs.

Indexed as

deubiquitinating enzymeDUB inhibitorpolyubiquitin chain linkageprotein array technologywheat cell-free system

Identifiers

PMID32512835
PMCPMC7344921
OpenAlexW3032893045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.